Similarly, in T98G glioblastoma cells treatment with ABT263 resulted in a significantly stronger anti-proliferative response among IDH1-mutated cells moving the respective IC50-values into the lower nanomolar range (Fig. 1b). Here, IDH1 is linked to glioblastoma.